3rd Quarter - Report

THE DUBERSTEIN GROUP INC. for PHRMA INC.

Firm
Client
Income
$75,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Drug pricing Outreach re: TRIPS waiver Issues related to the Food and Drug Amendments Act of 2022

LobbyistCovered position, as disclosed
BRIAN GRIFFIN —
BENJAMIN R HOWARD —
KATHERINE WINKLER KEATING —
DAVID J SCHIAPPA —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.